The effects of hypoglycemia and weight loss of total lignans from Fructus Arctii in KKAy mice and its mechanisms of the activity

Phytotherapy Research

Volumn 32, Issue 4, 2018, Pages 631-642

  Gao, Yingying ^a   Gu, Chenchen ^a   Wang, Kai ^a   Wang, Haiying ^a   Ruan, Kefeng ^a   Xu, Zhaohui ^a   Feng, Yi ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Fructus Arctii; hypoglycemic activity; KKAy mice; mechanism; weight loss

Indexed keywords

ADENOSINE PHOSPHATE; CARBOXYMETHYLCELLULOSE; FATTY ACID; FRUCTUS ARCTII EXTRACT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIGNAN; METFORMIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLANT EXTRACT; PROTEIN KINASE B; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARCTIUM LAPPA; ARTICLE; BODY WEIGHT; BODY WEIGHT LOSS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVATION; FATTY ACID BLOOD LEVEL; FRUCTUS ARCTII; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HYPOGLYCEMIA; INSULIN RELEASE; KK-AY MOUSE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORAL GLUCOSE TOLERANCE TEST; SIGNAL TRANSDUCTION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; C57BL MOUSE; CHEMISTRY; DIABETES MELLITUS; FRUIT; METABOLISM; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS; DRUGS, CHINESE HERBAL; FRUIT; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; MALE; MICE; MICE, INBRED C57BL; WEIGHT LOSS;

EID: 85045152309     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.6003     Document Type: Article

References (34)

1. Ahima, R. S. (2006). Adipose tissue as an endocrine organ. Obesity, 14 Suppl., 242S–249S.
2. American Diabetes Association (2011). Diagnosis and classification of diabetes mellitus. Diabetes Care, 35(Suppl. 1), S64–S71.
3. Bailey, S. D., Xie, C., Do, R., Montpetit, A., Diaz, R., Mohan, V., … DREAM Investigators (2010). Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes Reduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. Diabetes Care, 33, 2250–2253.
4. Chen, Z. H. (1999). Fructus Arctii is hypoglycemic and good for back and joints. Fujian J TCM, 30, 17.
5. China National Pharmacopoeia Commission (2015). Arctii Fructus. In Pharmacopoeia of the People 's Republic of China (Part 1, first ed.) (pp. 72). Beijing: China Medical Science and Technology Press.
6. DREAM Trail Investigators, Dagenais, G. R., Gerstein, H. C., Holman, R., Budaj, A., Escalante, A., … Yusuf, S. (2008). Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: Results of the Diabetes Reduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care, 31, 1007–1014.
7. Ferrannini, E. (1998). Insulin resistance versus insulin deficiency in non-insulin dependent diabetes mellitus: problems and prospects. Endocrine Reviews, 19, 477–490.
8. Holman, G. D., & Kasuqa, M. (1997). From receptor to transporter: Insulin signaling to glucose transport. Diabetologia, 40, 991–1003.
9. Huang, S. L., Yu, R. T., Gong, J., Feng, Y., Dai, Y. L., Hu, F., … Leng, Y. (2012). Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia, 55, 1469–1481.
10. Isomaa, B., Almgren, P., Tuomi, T., Forsen, B., Lahti, K., Nissen, M., … Groop, L. (2001). Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 24, 683–689.
11. Li, G. W., Pan, C. Y., & Li, H. (1997). Defects of using curve area ratio of glucose and insulin as the insulin sensitivity index in oral glucose tolerance test. Chinese Journal Internal Medicine, 36, 153–155.
12. Li, W. L., Zheng, H. C., Bukuru, J., & De Kimpe, N. (2004). Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology, 92, 1–21.
13. Liu, S. N., Liu, Q., Sun, S. J., Hou, S. C., Wang, Y., & Shen, Z. F. (2014). Metformin ameliorates β-cell dysfunction by regulating inflammation production, ion and hormone homeostasis of pancreas in diabetic KKAy mice. Acta Pharmaceutica Sinica, 49, 1554–1562.
14. Lu, J. S. (1998). Clinical observation on the use of Xiao-Ke Yin for the treatment of 60 Type 2 diabetic patients. N J Traditional Chinese Medicine, 30, 20–21.
15. Mancini, T., Mazziotti, G., Doga, M., Carpinteri, R., Simetovic, N., Vescovi, P. P., & Giustina, A. (2009). Vertebral fractures in males with Type 2 diabetes treated with rosiglitazone. Bone, 45, 784–788.
16. Mohammadi, J., & Naik, P. R. (2008). Evaluation of hypoglycemic effect of Morus alba in animal model. Indian Journal Pharmacology, 40, 15–18.
17. National Diabetes Prevention and Control Cooperative Group (1981). A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China. Chinese Journal Intern Medicine, 20, 83–678.
18. Orci, L., Cook, W. S., Ravazzola, M., Wang, M. Y., Park, B. H., Montesano, R., & Unger, R. H. (2004). Rapid transformation of white adipocytes into fat oxidizing machines. Proceedings of the National Academy of Sciences of the United States of America, 101, 2058–2063.
19. Otabe, S., Yuan, X., Fukutani, T., Wada, N., Hashinaga, T., Nakayama, H., … Yamada, K. (2007). Overexpression of human adiponectin in transgenic mice results in suppression of fat accumulation and prevention of premature death by high-calorie diet. American Journal of Physiology. Endocrinology and Metabolism, 293, 210–218.
20. Owen, M. R., Doran, E., & Halestrap, A. P. (2000). Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain. Biochemical Journal, 348, 607–614.
21. Portha, B. (2005). Programmed disorders of beta-cell development and function as one cause for Type 2 diabetes? The GK rat paradigm. Diabetes/Metabolism Research and Reviews, 21, 495–504.
22. Shulman, G. I. (2000). Cellular mechanisms of insulin resistance. Journal of Clinical Investigation, 106, 171–176.
23. Srinivasan, K., & Ramarao, P. (2007). Animal models in Type 2 diabetes research: An overview. Indian Journal of Medical Research, 125, 451–472.
24. Stratton, I. M., Adler, A. I., Neil, H. A., Matthews, D. R., Manley, S. E., Cull, C. A., … Holman, R. R. (2000). Association of glycaemia with macrovascular and microvascular complications of Type 2 diabetes (UKPDS 35): Prospective observational study. BMJ, 321, 405–412.
25. Tsou, R. C., & Bence, K. K. (2012). Central regulation of metabolism by protein tyrosine phosphatases. Frontiers in Neuroscience, 6, 192.
26. World Health Organization. (1999). Definition, diagnosis and classification of diabetes mellitus and its complications, part 1: Report of the WHO Consultation Geneva (Tech. Report. Ser No. WHO/NCD/NCS/99.2):1999.
27. Xu, Y., Wang, L. M., He, J., Bi, Y. F., Li, M., Wang, T. G., … Ning, G. (2013). Prevalence and control of diabetes in Chinese adults. JAMA, 310, 59–948.
28. Xu, Z. H., Ju, J. X., Wang, K., Gu, C. C., & Feng, Y. (2014). Evaluation of hypoglycemic activity of total lignans from Fructus Arctii in the spontaneously diabetic Goto-Kakizaki rats. Journal of Ethnopharmacology, 151, 548–555.
29. Xu, Z. H., Wang, X. Y., Zhou, M. M., Ma, L. P., Deng, Y., Zhang, H. J., … Jia, W. (2008). The antidiabetic activity of total lignan from Fructus Arctii against alloxan-induced diabetes in mice and rats. Phytotherapy Research, 22, 97–101.
30. Xu, Z. H., Zhao, A. H., Gao, X. F., & Jia, W. (2006). Chemical constituents of anti-hyperglycemic active fraction from Arctium lappa. Chinese Journal of Natural Medicines, 4, 444–447.
31. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., … Kadowaki, T. (2002). Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nature Medicine, 8, 1288–1295.
32. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., … Kadowaki, T. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine, 7, 941–946.
33. Yatagai, T., Nagasaka, S., Taniguchi, A., Fukushima, M., Nakamura, T., Kuroe, A., … Ishibashi, S. (2003). Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with Type 2 diabetes mellitus. Metabolism, 52, 1274–1278.
34. Zhai, X. H., Xu, Z. H., Qiu, M. F., & Jia, W. (2009). Study on quality standard of Tangshenkang soft capsules. Chinese Traditional Pat Medicine, 31, 1708–1711.